Wells Fargo & Company Grifols Sa Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

A detailed history of Wells Fargo & Company transactions in Grifols Sa stock. As of the latest transaction made, Wells Fargo & Company holds 871,888 shares of GRFS stock, worth $7.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

871,888

Previous 817,827 6.61%

Holding current value

$7.59 Million

Previous $7.39 Million 17.46%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$8.87 - $10.85 $479,521 - $586,561	54,061 Added 6.61%	871,888 $8.68 Million
Q2 2025 Aug 14, 2025	BUY	$6.49 - $9.09 $321,358 - $450,100	49,516 Added 6.44%	817,827 $7.39 Million
Q1 2025 May 13, 2025	BUY	$6.62 - $8.71 $945,719 - $1.24 Million	142,858 Added 22.84%	768,311 $5.46 Million
Q4 2024 Feb 12, 2025	SELL	$6.99 - $9.55 $472,146 - $645,064	-67,546 Reduced 9.75%	625,453 $4.65 Million
Q3 2024 Nov 13, 2024	SELL	$6.28 - $9.38 $219,278 - $327,521	-34,917 Reduced 4.8%	692,999 $6.15 Million

Q2 2024 Aug 13, 2024	BUY	$6.27 - $7.7 $1.17 Million - $1.43 Million	186,099 Added 34.35%	727,916 $4.59 Million
Q1 2024 May 10, 2024	BUY	$5.47 - $11.38 $138,795 - $288,756	25,374 Added 4.91%	541,817 $3.62 Million
Q4 2023 Feb 09, 2024	BUY	$7.71 - $11.56 $407,820 - $611,466	52,895 Added 11.41%	516,443 $5.97 Million
Q3 2023 Nov 13, 2023	SELL	$8.91 - $10.91 $67,787 - $83,003	-7,608 Reduced 1.61%	463,548 $4.24 Million
Q2 2023 Aug 15, 2023	BUY	$7.14 - $9.29 $25,225 - $32,821	3,533 Added 0.76%	471,156 $4.32 Million
Q1 2023 May 12, 2023	BUY	$6.65 - $10.69 $399,006 - $641,410	60,001 Added 14.72%	467,623 $3.45 Million
Q4 2022 Feb 13, 2023	SELL	$5.96 - $8.53 $283,582 - $405,865	-47,581 Reduced 10.45%	407,622 $3.46 Million
Q3 2022 Nov 14, 2022	SELL	$5.95 - $14.3 $70,781 - $170,112	-11,896 Reduced 2.55%	455,203 $2.8 Million
Q2 2022 Aug 12, 2022	BUY	$10.6 - $13.28 $145,538 - $182,334	13,730 Added 3.03%	467,099 $5.55 Million
Q1 2022 May 16, 2022	BUY	$10.37 - $12.73 $1.33 Million - $1.63 Million	128,005 Added 39.34%	453,369 $5.3 Million
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $7,208 - $10,780	706 Added 0.22%	325,364 $3.65 Million
Q3 2021 Nov 15, 2021	SELL	$14.07 - $17.3 $453,954 - $558,167	-32,264 Reduced 9.04%	324,658 $4.74 Million
Q2 2021 Aug 16, 2021	BUY	$16.62 - $18.94 $477,575 - $544,240	28,735 Added 8.76%	356,922 $6.19 Million
Q1 2021 May 13, 2021	BUY	$15.15 - $19.78 $717,125 - $936,286	47,335 Added 16.85%	328,187 $5.67 Million
Q4 2020 Feb 09, 2021	BUY	$16.86 - $19.67 $1.45 Million - $1.69 Million	85,827 Added 44.01%	280,852 $5.18 Million
Q3 2020 Nov 05, 2020	SELL	$15.4 - $20.16 $172,110 - $225,308	-11,176 Reduced 5.42%	195,025 $3.38 Million
Q2 2020 Aug 13, 2020	BUY	$18.24 - $21.45 $220,995 - $259,888	12,116 Added 6.24%	206,201 $3.76 Million
Q1 2020 May 14, 2020	BUY	$16.28 - $25.63 $3.16 Million - $4.97 Million	194,085 New	194,085 $3.91 Million

Others Institutions Holding GRFS

# of Institutions

200

Shares Held

148M

Call Options Held

76.1K

Put Options Held

58.2K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.91B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Grifols Sa Transaction History